DI SCALA, GERARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.527
EU - Europa 1.704
AS - Asia 968
SA - Sud America 117
AF - Africa 45
OC - Oceania 5
Totale 5.366
Nazione #
US - Stati Uniti d'America 2.480
RU - Federazione Russa 644
IT - Italia 489
SG - Singapore 270
CN - Cina 223
HK - Hong Kong 152
IE - Irlanda 125
SE - Svezia 95
VN - Vietnam 91
BR - Brasile 90
KR - Corea 74
FR - Francia 73
PL - Polonia 72
FI - Finlandia 59
DE - Germania 45
BD - Bangladesh 44
IN - India 38
CH - Svizzera 35
CA - Canada 26
GB - Regno Unito 26
CI - Costa d'Avorio 24
JO - Giordania 24
AR - Argentina 10
ID - Indonesia 10
NL - Olanda 10
MX - Messico 9
ES - Italia 8
MA - Marocco 8
EC - Ecuador 7
IQ - Iraq 7
AT - Austria 6
JP - Giappone 5
UA - Ucraina 5
AU - Australia 4
PE - Perù 4
VE - Venezuela 4
ZA - Sudafrica 4
DO - Repubblica Dominicana 3
PH - Filippine 3
SA - Arabia Saudita 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
MC - Monaco 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
QA - Qatar 1
SO - Somalia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 5.366
Città #
Santa Clara 566
Ashburn 358
Singapore 181
Fairfield 171
Dublin 125
Hong Kong 123
Milan 113
Chandler 110
San Jose 110
Seattle 84
Houston 78
Woodbridge 77
Seoul 73
Warsaw 72
Beijing 53
Lawrence 53
Altamura 52
Cambridge 52
Buffalo 51
Wilmington 51
Florence 48
Helsinki 43
Los Angeles 43
Rome 43
Moscow 42
New York 40
Bern 33
Boston 30
Princeton 30
Paris 29
Dallas 26
Lauterbourg 26
Ho Chi Minh City 25
Abidjan 24
Mumbai 24
Ann Arbor 22
Hanoi 22
Shanghai 21
The Dalles 20
Munich 19
Hefei 17
Council Bluffs 16
Turin 15
Boardman 13
São Paulo 13
Kent 12
San Diego 11
Turku 11
Bari 10
Bologna 10
Jakarta 9
Orem 9
Clifton 8
Guangzhou 8
Medford 8
Naples 8
Brooklyn 7
Casablanca 7
Chicago 7
Falls Church 7
Redwood City 7
Toronto 7
Catania 6
Da Nang 6
Dong Ket 6
Vienna 6
Belo Horizonte 5
Chennai 5
Figino 5
Frankfurt am Main 5
Jinan 5
Lappeenranta 5
Norwalk 5
Palermo 5
Phoenix 5
Stockholm 5
Denver 4
Haiphong 4
Hillsboro 4
London 4
Melbourne 4
Montreal 4
Napoli 4
North Bergen 4
Tokyo 4
Venice 4
Washington 4
Amman 3
Baghdad 3
Brescia 3
Cagliari 3
Charlemont 3
Guayaquil 3
Padova 3
Padua 3
Redmond 3
Rieti 3
Taiyuan 3
Tashkent 3
Yubileyny 3
Totale 3.540
Nome #
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 305
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 261
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 260
Practice parameters for sublingual immunotherapy 210
Intravenous immunoglobulin therapy: a snapshot for the internist. 209
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 204
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 201
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 200
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 197
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 194
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 188
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 187
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 177
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 166
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 160
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 160
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 153
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 152
Vascular Behçet's syndrome: an update 149
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 148
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 143
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis 142
Different Drug Survival of First Line Tumour Necrosis Factor Inhibitors in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Multicentre Retrospective Survey 141
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 140
Prompt Clinical Response to Secukinumab in Patients With Axial Spondyloarthritis: Real Life Observational Data From Three Italian Referral Centers 133
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts 132
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network 127
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 121
Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4) 118
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 115
Subclinical and Clinical Atherosclerosis in Rheumatoid Arthritis: Results From the 3-year, Multicentre, Prospective, Observational GIRRCS (Gruppo Italiano Di Ricerca in Reumatologia Clinica E Sperimentale) Study 111
Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial 110
Totale 5.414
Categoria #
all - tutte 17.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 1 8 32 12 2 12 3 30 14 10 47 64
2022/2023595 54 164 20 14 30 88 71 29 62 8 17 38
2023/2024283 12 24 37 19 24 40 16 53 4 18 15 21
2024/20251.650 61 180 76 299 488 175 39 79 82 57 70 44
2025/20261.886 200 206 129 133 184 75 220 75 108 138 55 363
2026/202732 32 0 0 0 0 0 0 0 0 0 0 0
Totale 5.414